EFTA Document EFTA01457174

From: Daniel Sabba Sent: 4/13/2015 8:20:30 AM To: Jeffrey E. (jeevacation@ mail corn] CC: Vahe Ste anion Subject: Ariane Dw er ; Richard Kahn I FW: Google Ventures' Mark Fully Invested in Idea of Living to (CJ Classification: Confidential ; Paul Morris Not sure if you saw this in the Bloomberg Magazine, but Foundation Medicine is extensively debated (a "Google for oncologists"). I marked relevant paragraphs in bold. Original Message From: Daniel Sabba (DEUTSCHE BANK SECURI) [mailto: ] Sent: Monday, April 13, 2015 8:14 AM Subject: (BN) Google Ventures' Maris Fully Invested in Idea of Living to (BN) Google Ventures' Maris Fully Invested in Idea of Living to 500 This has been prepared solely for informational purposes. It is not an offer, recommendation or solicitation to buy or sell, nor is it an official confirmation of terms. It is based on information generally available to the public from sources believed to be reliable. No representation is made that it is accurate or complete or that any returns indicated will be achieved. Changes to assumptions may have a material impact on any returns detailed. Past performance is not indicative of future returns. Price and availability are subject to change without notice. Additional information is available upon request. Google Ventures' Maris Fully Invested in Idea of Living to 500 2015-03-09 04:01:04.69 GMT By Katrina Brooker (Bloomberg Business) -- "If you ask me today, is it possible to live to be 500? The answer is yes," Bill Maris says one January afternoon in Mountain View, California. The president and managing partner of Google Ventures just turned 40, but he looks more like a 19-year-old college kid at midterm. He's wearing sneakers and a gray denim shirt over a T-shirt; it looks like he hasn't shaved in a few days. Behind him, sun is streaming through a large wall of windows. Beyond is the leafy expanse of the main Google campus. Inside his office, there's not much that gives any indication of the work Maris does here, Bloomberg Markets will report in its April 2015 issue. The room is sparse—clean white walls, a few chairs, a table. On this day, his desk has no papers, no notepads or Post-its, not even a computer. Here's where you really figure out who Bill Maris is: on his bookshelf. There's a fat text called Molecular Biotechnology: Principles and Applications of Recombinant DNA. There's a well-read copy of Biotechnology: Applying the Genetic Revolution. And a collection of illustrations by Fritz Kahn, a German physician who was among the first to depict the CONFIDENTIAL — PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0 116592 CONFIDENTIAL SDNY_GM_00262776 EFTA01457174